SWS Partners’s Exelixis EXEL Stock Holding History

SWS Partners’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,514	Closed	-$46K	–	392
2017 Q4	$46K	Buy	+1,514	New	+$40.3K	0.03%	149

Other funds holding EXEL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

SWS Partners's EXEL Position: Q1 2018 in Review

SWS Partners sold out of Exelixis (EXEL) in Q1 2018, closing a stake of 1,514 shares — an estimated $46K sold.

SWS Partners first reported a position in EXEL in Q4 2017 and held it in 1 quarter. The position peaked at $46K in Q4 2017. 294 funds tracked by Wall St. Rank hold EXEL as of Q1 2018.

SWS Partners reported no remaining Exelixis position as of Q1 2018 after selling out during the quarter.
SWS Partners sold 1,514 Exelixis shares in Q1 2018, an estimated $46K.
SWS Partners first reported a position in Exelixis in Q4 2017 and held it in 1 quarter.
SWS Partners's Exelixis position peaked at $46K in Q4 2017.
294 funds tracked by Wall St. Rank held Exelixis as of Q1 2018.

Based on SWS Partners's 13F filing for Q1 2018, filed 15 May 2018.